Article thumbnail

Prevalence of NAFLD in Healthy and Young Male Individuals

By Asif Niaz, Zafar Ali, Shaista Nayyar and Naureen Fatima


Introduction. Nonalcoholic fatty liver disease (NAFLD) is an important cause of liver disease in adults and the most common cause of liver disease in children (Lavine and Schwimmer 2004). The abnormalities include increased liver fat without inflammation (steatosis) and nonalcoholic steatohepatitis (NASH). NASH may lead to fibrosis, cirrhosis, and ultimately liver failure if it is not treated (Matteoni et al. 1999). The objective of the study is to estimate the magnitude of the problem which will help us to formulate strategies in managing the potentially difficult problem. Materials and Methods. We included 1000 individuals between the ages of 30 and 50 years who came for annual checkup. The patients with other comorbidities like diabetes, ischemic heart disease, chronic liver disease, or renal diseases were excluded from the study. History of alcohol ingestion was also taken; any individual with history of alcohol intake was also excluded. All of them underwent investigations including CBC, LFTs, height and weight. The individuals who were found to have increased ALT (50 to 150 u/L) further underwent investigations including ultrasound of abdomen hepatitis b and c serology RA and ANA antibodies. All the individuals who were found to have viral or autoimmune illness were excluded from the study. The individuals having raised ALT levels and ultrasound evidence of fatty liver were taken. Results. 13.5% of the individuals were found to have NAFLD among those selected for the study. Conclusion. Mass campaign regarding physical and dietary measures needs to be undertaken in general masses regarding the gravity and potential prevention of the disease

Topics: Research Article
Publisher: International Scholarly Research Network
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1995). A.Lonardo,M.Bellini,E.Tondellietal.,“Nonalcoholicsteatohepatitis and the “bright liver syndrome”: should a recently expanded clinical entity be further expanded?”
  2. (2006). Abrams, “The prevalence of nonalcoholic steatohepatitis
  3. (1988). Alcohollike liver disease in nonalcoholics.A clinical and histologiccomparison with alcohol-induced liver injury,”
  4. (2005). andG.I.Shulman,“Reversalofnonalcoholichepaticsteatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction
  5. (1999). Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease,” Hepatology,
  6. (2007). Lesmana et al., “How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?”
  7. (2006). Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression,”
  8. (1999). M a t t e o n i ,Z .M .Y o u n o s s i ,T .G r a m l i c he ta l . ,“ N o n a l c o -holicfattyliver disease:aspectrum ofclinicalandpathological severity,”
  9. (1996). Modulation of insulin activities by leptin,”
  10. (2010). Niemeieret al.,“Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis,”
  11. (2007). Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines,”
  12. (2009). Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance,”
  13. (2004). Nonalcoholic fatty liver disease in the pediatric population,”
  14. (2004). Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss,”
  15. (1994). Nonalcoholic steatohepatitis: an expanded clinical entity,”
  16. (2000). o ,A .V e r g a n i ,P .T r o m b i n i ,M .P o z z i ,F .P a l e a r i ,a n d A.Piperno,“Insulinresistanceinfluencesironmetabolismand hepaticsteatosisintype IIdiabetes,”
  17. (1990). P o w e l l ,W .G .E .C o o k s l e y ,R .H a n s o n ,J .S e a r l e
  18. (2007). Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis,”
  19. (1999). The ratio of aspartate aminotransferaseto alanine aminotransferase:potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease,”
  20. (1979). The SGOT/SGPT ratio. An indicator of alcoholic liver disease,”